PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19337085-10	2009	BMP-2 was released from polycaprolactone over 2 weeks, with 86 percent remaining covalently bound, in contrast to 93 percent retained by poly(lactic-co-glycolic acid).	polycaprolactone	24-40	bone morphogenetic protein 2	Mus musculus	0-5	
33997495-2	2021	Based on soybean-lecithin as an adjuvant biosurfactant, we designed a novel cell-free-scaffold of polymer of poly(epsilon-caprolactone) and poly(lactide-co-glycolide)-co-polyetherimide with abundant entrapped and continuously released BMP2 for in vivo stem cell-capture and in situ osteogenic induction, avoiding the use of exogenous cells.	polycaprolactone	109-135	bone morphogenetic protein 2	Mus musculus	235-239	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	150-153	bone morphogenetic protein 2	Mus musculus	46-72	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	150-153	bone morphogenetic protein 2	Mus musculus	74-79	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	150-153	bone morphogenetic protein 2	Mus musculus	46-72	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	150-153	bone morphogenetic protein 2	Mus musculus	74-79	
30445673-2	2018	The BMP-2/TA/PCL scaffold showed controlled and sustained BMP-2 release.	polycaprolactone	13-16	bone morphogenetic protein 2	Mus musculus	4-9	
30445673-2	2018	The BMP-2/TA/PCL scaffold showed controlled and sustained BMP-2 release.	polycaprolactone	13-16	bone morphogenetic protein 2	Mus musculus	58-63	
25842103-0	2015	Nanofibrous yet injectable polycaprolactone-collagen bone tissue scaffold with osteoprogenitor cells and controlled release of bone morphogenetic protein-2.	polycaprolactone	27-43	bone morphogenetic protein 2	Mus musculus	127-155	
32911737-3	2020	Recently, bone neoformation was demonstrated after in vivo implantation of polycaprolactone (PCL) biomembranes functionalized with bone morphogenic protein 2 (BMP-2) and ibuprofen in a mouse maxillary bone lesion.	polycaprolactone	75-91	bone morphogenetic protein 2	Mus musculus	131-157	
32911737-3	2020	Recently, bone neoformation was demonstrated after in vivo implantation of polycaprolactone (PCL) biomembranes functionalized with bone morphogenic protein 2 (BMP-2) and ibuprofen in a mouse maxillary bone lesion.	polycaprolactone	75-91	bone morphogenetic protein 2	Mus musculus	159-164	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	103-119	bone morphogenetic protein 2	Mus musculus	46-72	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	103-119	bone morphogenetic protein 2	Mus musculus	74-79	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	103-119	bone morphogenetic protein 2	Mus musculus	127-132	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	103-119	bone morphogenetic protein 2	Mus musculus	127-132	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	121-124	bone morphogenetic protein 2	Mus musculus	46-72	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	121-124	bone morphogenetic protein 2	Mus musculus	74-79	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	121-124	bone morphogenetic protein 2	Mus musculus	127-132	
30445673-1	2018	In this study, a novel three-dimensional (3D) bone morphogenic protein-2 (BMP-2)-delivering tannylated polycaprolactone (PCL) (BMP-2/tannic acid (TA)/PCL) scaffold with anti-oxidant, anti-inflammatory, and osteogenic activities was fabricated via simple surface coating with TA, followed by the immobilization of BMP-2 on the TA-coated PCL scaffold.	polycaprolactone	121-124	bone morphogenetic protein 2	Mus musculus	127-132	
29682553-3	2018	In vivo implantation of polycaprolactone (PCL) biomembrane functionalized with BMP-2/Ibuprofen in mouse maxillary defects was followed by bone neoformation kinetics evaluation using microcomputed tomography.	polycaprolactone	24-40	bone morphogenetic protein 2	Mus musculus	79-84	
29682553-3	2018	In vivo implantation of polycaprolactone (PCL) biomembrane functionalized with BMP-2/Ibuprofen in mouse maxillary defects was followed by bone neoformation kinetics evaluation using microcomputed tomography.	polycaprolactone	42-45	bone morphogenetic protein 2	Mus musculus	79-84	
23164422-3	2013	We have shown that bone morphogenetic protein (BMP) 2 activates the Smad pathway only in murine MC3T3-E1 preosteoblasts attached to polycaprolactone (PCL) film functionalized by RGD peptides derived from bone sialoprotein (pRGD).	polycaprolactone	132-148	bone morphogenetic protein 2	Mus musculus	19-53	
23164422-3	2013	We have shown that bone morphogenetic protein (BMP) 2 activates the Smad pathway only in murine MC3T3-E1 preosteoblasts attached to polycaprolactone (PCL) film functionalized by RGD peptides derived from bone sialoprotein (pRGD).	polycaprolactone	150-153	bone morphogenetic protein 2	Mus musculus	19-53